About Unchained Labs
Unchained Labs is a company based in Pleasanton (United States) founded in 2015 by Tim Harkness was acquired by The Carlyle Group in April 2021. Unchained Labs has raised $111 million across 7 funding rounds from investors including SVB, Golub Capital and The Carlyle Group. Unchained Labs has completed 6 acquisitions, including AVIA Biosystems, Blacktrace and Freeslate. Unchained Labs offers products and services including Aunty, Stunner, Honeybun, Unagi, and Leprechaun. Unchained Labs operates in a competitive market with competitors including Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
- Headquarter Pleasanton, United States
- Founders Tim Harkness
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$111 M (USD)
in 7 rounds
-
Latest Funding Round
$155 M (USD), Debt – Conventional
Aug 10, 2021
-
Investors
SVB
& 7 more
-
Employee Count
Not available
-
Investments & Acquisitions
AVIA Biosystems
& 5 more
-
Acquired by
The Carlyle Group
(Apr 26, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Unchained Labs
Unchained Labs offers a comprehensive portfolio of products and services, including Aunty, Stunner, Honeybun, Unagi, and Leprechaun.
High-throughput tool for protein stability characterization in biologics.
Device for quantification and sizing of biologics and gene therapy samples.
Rapid viscometer for measuring viscosity in scientific formulations.
Automated system for buffer exchange and sample preparation workflows.
Instrument for lentivirus and exosome characterization in cell therapy.
Automated screener for LNP formulation optimization processes.
People of Unchained Labs
Unlock access to complete
Unlock access to complete
Funding Insights of Unchained Labs
Unchained Labs has successfully raised a total of $111M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $155 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Unchained Labs
Unchained Labs has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Golub Capital and The Carlyle Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt funds are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked |
Investor details for Unchained Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Unchained Labs
Unchained Labs has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include AVIA Biosystems, Blacktrace and Freeslate.
Investment portfolio details for Unchained Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Nanotechnology-based platform for single biomolecule detection is provided.
|
Locked | Locked | 2015 | Locked | |
|
Isothermal Chemical Denaturation (ICD) system for measuring biologic stability
|
Locked | Locked | 2012 | Locked | |
|
High-throughput automation products for research are provided by Freeslate.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Unchained Labs
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Unchained Labs
Detailed financials for Unchained Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Unchained Labs Comparisons
Peer comparison for Unchained Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Unchained Labs
Unchained Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
|
| Locked | Locked | Locked |
Diversified instruments are developed for scientific and laboratory management.
|
Detailed competitors of Unchained Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Unchained Labs
Complete news archive for Unchained Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unchained Labs
Unchained Labs was founded in 2015.
Unchained Labs is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Tim Harkness is the current CEO of Unchained Labs. They have also founded this company.
Unchained Labs is a funded company, having raised a total of $111M across 7 funding rounds to date.
Unchained Labs was founded in 2015 in Pleasanton, United States, within the biotechnology sector. A multiplex platform called Optim is provided for assessing protein stability in biologics, where parameters such as denaturing temperature and aggregation onset are measured across multiple samples. Applications include lead candidate selection, optimization, pre-formulation studies, formulation development, and ongoing stability evaluations for research purposes.
Unchained Labs's top competitors include Cepheid, Blackrock Neurotech and Agilent.
Unchained Labs offers Aunty, Stunner, Honeybun, Unagi, and 2 more products and services.
Unchained Labs has made 6 acquisitions, including AVIA Biosystems, Blacktrace, and Freeslate.
Unchained Labs has 8 investors. Key investors include SVB, Golub Capital, The Carlyle Group, TPG, and MidCap Financial.